Robert S. Coffin

7.0k total citations
66 papers, 3.5k citations indexed

About

Robert S. Coffin is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Robert S. Coffin has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 25 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Robert S. Coffin's work include Virus-based gene therapy research (44 papers), Herpesvirus Infections and Treatments (25 papers) and CAR-T cell therapy research (18 papers). Robert S. Coffin is often cited by papers focused on Virus-based gene therapy research (44 papers), Herpesvirus Infections and Treatments (25 papers) and CAR-T cell therapy research (18 papers). Robert S. Coffin collaborates with scholars based in United Kingdom, United States and India. Robert S. Coffin's co-authors include David S. Latchman, Kevin J. Harrington, Howard L. Kaufman, Colin Love, Howard Goldsweig, Neil Senzer, Thomas Amatruda, Marcus Wagstaff, Iain A. McNeish and Christopher M. Nutting and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Robert S. Coffin

65 papers receiving 3.4k citations

Peers

Countries citing papers authored by Robert S. Coffin

Since Specialization

Citations

This map shows the geographic impact of Robert S. Coffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Coffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Coffin more than expected).

Fields of papers citing papers by Robert S. Coffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Coffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Coffin. The network helps show where Robert S. Coffin may publish in the future.

Co-authorship network of co-authors of Robert S. Coffin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Coffin. A scholar is included among the top collaborators of Robert S. Coffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Coffin. Robert S. Coffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer	Journal for ImmunoTherapy of Cancer	Katharina Bergerhoff, Shane Foo et al.	24
2	An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.	Journal of Clinical Oncology	Mark R. Middleton, Francesca Aroldi et al.	16
3	Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma	PubMed	Howard L. Kaufman, Caroline E. Lilley et al.	18
4	Primary overall survival (OS) from OPTiM, a randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.	Journal of Clinical Oncology	Howard L. Kaufman, Robert Hans Ingemar Andtbacka et al.	36
5	Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck	Clinical Cancer Research	Kevin J. Harrington, Mohan Hingorani et al.	216
6	A Third-Generation Herpesvirus Is Effective Against Gastroesophageal Cancer	Journal of Surgical Research	Joyce Wong, Kaitlyn J. Kelly et al.	9
7	Oncolysis Using Herpes Simplex Virus Type 1 Engineered to Express Cytosine Deaminase and a Fusogenic Glycoprotein for Head and Neck Squamous Cell Carcinoma	Archives of Otolaryngology - Head and Neck Surgery	Daniel L. Price, Shu‐Fu Lin et al.	10
8	Delivery of RNA interference triggers to sensory neuronsin vivousing herpes simplex virus	Expert Opinion on Biological Therapy	Robert S. Coffin et al.	6
9	Delivery of HPV Antigens Using a Modified HSV-2 Vector: Development of a Combined Vaccine for HPV and HSV-2	Central European Journal of Public Health	Mark Thornton, Philip A. Reay et al.	1
10	Impaired Axonal Regeneration by Isolectin B4-Binding Dorsal Root Ganglion NeuronsIn Vitro	Journal of Neuroscience	Pascal G Leclere, Robert S. Coffin et al.	63
11	VASCULAR ENDOTHELIAL GROWTH FACTOR GENE-TRANSFERRED BONE MARROW STROMAL CELLS ENGINEERED WITH A HERPES SIMPLEX VIRUS TYPE 1 VECTOR CAN IMPROVE NEUROLOGICAL DEFICITS AND REDUCE INFARCTION VOLUME IN RAT BRAIN ISCHEMIA	Neurosurgery	Naosuke Nonoguchi, Naokado Ikeda et al.	47
12	Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury	Journal of Neuroscience Research	Kazuya Kitamura, Akio Iwanami et al.	133
13	Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity	The Journal of Infectious Diseases	Gabriele Pollara, Laila Samady et al.	102
14	Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss	Molecular Brain Research	Mohammed T. Akbar, Robert S. Coffin et al.	50
15	Impact of Process Conditions on the Centrifugal Recovery of a Disabled Herpes Simplex Virus	Biotechnology Progress	M. Susana Levy, Robert S. Coffin et al.	8
16	In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors	Basic Research in Cardiology	Matthew Wright, Lionel Wightman et al.	74
17	Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium	Cornea	Tobias Hudde, Sandra Rayner et al.	42
18	Viral vectors in the treatment of Parkinson's disease	Movement Disorders	David S. Latchman, Robert S. Coffin	19
19	Cell type specific repression of the varicella zoster virus immediate early gene 62 promoter by the cellular Oct-2 transcription factor	Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression	Gerald Gough, Robert S. Coffin et al.	9
20	Focal cerebral ischaemia increases the levels of several classes of heat shock proteins and their corresponding mRNAs	Molecular Brain Research	Marcus Wagstaff, Yolanda Collaço‐Moraes et al.	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact